Schisandra Market is expected to grow with a CAGR of 7.56% during the forecast period 2020-2027.

Syndicated report on "Schisandra Market – Size, Share and Forecast (2020-2027)" has been added to DataM Intelligence’s product offering.

Market Overview

Schisandra (Schisandra chinensis) is a plant whose deep red berries have long been used in traditional Chinese medicine. Schisandra is a deciduous climbing vine native to China and Russia that thrives in almost all types of soils. Schisandra berries are referred to as wu wei zi in traditional Chinese medicine and omicha in Korea. In traditional Chinese medicine, Schisandra is considered an "adaptogen," meaning a plant or herb that balances the body's functions and maintains homeostasis. The berry itself is often called "five-flavor berry" because it possesses all five of the basic flavors of Chinese herbal medicine: salty, sweet, sour, spicy, and bitter. Having these flavors means that it can benefit all five yin organs: the liver, lungs, heart, kidneys, and spleen. Schisandra berries also provide powerful antioxidant protection, particularly from free radicals and other toxins in the environment that may cause cellular damage. In Traditional Chinese Medicine (TCM), Schisandra is believed to have anti-aging properties and to promote physical, emotional, and even sexual stamina. The berries or seeds may be used to treat cough, asthma, indigestion, diarrhea, flu, insomnia, skin allergy, heart palpitations, insulin resistance, and premenstrual syndrome, among other things. Due to its various advantages the market for Schisandra is expected to grow with a CAGR of 7.56% during the forecast period. Schisandra market value is likely to reach USD 15,662.17 thousand in 2027, from its recorded value of USD 8,746.13 thousand in 2019.  Schisandra Chinensis contributed for highest market revenue share in the global Schisandra market, owing to its increasing usage in various end use industries. Asia Pacific dominated the global Schisandra market with market revenue share of 66% in the year 2019. China held the highest market revenue share in the Asia Pacific Schisandra market. 

Market Dynamics

Drivers

  • Health benefits of Schisandra is expected to drive the market growth
  • Increasing demand for phytomedicines & Schisandra extracts

Restraints

  • Presence of health-related side-effects through excessive consumption of Schisandra

Health benefits of Schisandra is expected to drive the market growth

Schisandra is used for a wide range of health-related issues. There’s some scientific data from animal and human studies that indicate Schisandra may have a positive effect on several conditions and diseases. For instance, a 2017 study Trusted Source found that Schisandrin B had a beneficial, positive effect on Alzheimer’s disease. Researchers determined that this was caused by Schisandrin B’s ability to block formation of excess amyloid beta peptides in the brain. These peptides are one of the components responsible for forming amyloid plaque, a substance found in the brains of people with Alzheimer’s disease. Another study indicates that Schisandrin B may be effective against both Alzheimer’s and Parkinson’s disease. This is due to its anti-inflammatory, neuroprotective effect upon microglial cells in the brain. A 2016 study analyzed the effects of Schisandra extract on women with menopausal symptoms. The study followed 36 menopausal women for one year. Researchers determined that Schisandra is effective at alleviating some symptoms of menopause.  A 2013 animal study found that pollen extracted from the Schisandra plant had a strong, antioxidant effect against toxic damage that was induced in the livers of mice. Schisandrin C was effective against liver damage in people with both acute and chronic hepatitis, a liver disease. Another recent animal study found that Schisandra extract had an antidepressant effect on mice. Additional mouse studiesTrusted Source, run by the same lead researcher, solidified this finding. However, Schisandra and its potential effect on depression hasn’t been extensively studied in humans. Schisandra also has adaptogenic properties which help the body resist the effects of anxiety and stress, plus bolster the body’s defenses against stress. Additionally, schisandra offers great benefits for athletes.

Geographical Analysis

South America is estimated to account for a share of 3% in total dollar sales in 2019. The South America Schisandra market valued USD 283.53 thousand in 2019 and is estimated to reach USD 412.04 thousand by 2027, growing at a CAGR of 4.91% during the forecast period. Brazil dominated the South America Schisandra market with market revenue share of 92% in 2019. Brazilians are becoming more interested in “safe” and “natural” treatments aimed to promote healthier living. In September 2019, China-Brazil International Cooperation Base of Chinese Medicine Products began its trial operation in the city of Sao Paulo, the capital of the state of Sao Paulo. In 2019, the planting area of Chinese medicinal herbs across the province reached about 306,667 hectares. China and Brazil are also pushing for legislation of TCM in Brazil. Brazil adheres to the EU standards on food and drug supervision and regulation. In recent years, Lanzhou Foci Pharmaceuticals Co. has been actively promoting the TCM legislation and standardization by providing references for quality standards of medicinal-herb-based medicine written in the Pharmacopoeia of China and adverse drug reaction monitoring reports to the National Congress of Brazil and the country's health and drug authorities. Hence, the promotion of TCM in Brazil, acts as a key opportunity for Schisandra market players in Brazil. Florien is one of the key players in Brazil offering Schisandra dry extract. On the other hand, Argentina Schisandra market value is likely to reach USD 17.15 thousand in 2027, from its recorded value of USD 12.95 thousand in 2019, growing with a CAGR of 3.80% during the forecast period. 

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

Found it interesting?

Email: [email protected]
US: +1 877 441 4866

We have 5000+ marketing reports and serve across 100+ countries